Only followers of this user (@JazzyMama) can see their posts
In response Lisa Groenewoud to her Publication
Who owns remdesivir, how much can they make, and how much does it cost? | Ars Technica
The drug was originally developed for Ebola but has shown promise with COVID-19.
https://arstechnica.com/science/2020/04/who-owns-remdesivir-how-much-can-they-make-and-how-much-does-it-cost/